Synthesis and pharmacological evaluation of novel isoquinoline N-sulphonylhydrazones designed as ROCK inhibitors

References

• Riento K, Ridley AJ. Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol 2003;4:446–56.
   PubMed Web of Science ®Google Scholar
• Julian L, Olson MF. Rho-associated coiled-coil containing kinases (ROCK): structure, regulation, and functions). Small GTPases 2014;5:e29846
   PubMedGoogle Scholar
• Feng Y, Lograsso PV, Defert O. Rho kinase (ROCK) inhibitors and their therapeutic potential. J Med Chem 2016;59:2269–300.
   PubMed Web of Science ®Google Scholar
• Mueller BK, Mack H, Teusch N. Rho kinase, a promising drug target for neurological disorders. Nat Rev Drug Discov 2005;4:387–98.
   PubMed Web of Science ®Google Scholar
• Glyn M. A Rho-associated kinase mitigates reperfusion-induced change in the shape of cardiac capillary endothelial cells in situ. Cardiovasc Res 2003;57:195–206.
   PubMed Web of Science ®Google Scholar
• Stroeken PJM, Alvarez B, Rheenen J, van,et al. Integrin cytoplasmic domain-associated protein-1 (ICAP-1) interacts with the ROCK-I kinase at the plasma membrane. J Cell Physiol 2006;208:620–8.
   PubMed Web of Science ®Google Scholar
• Leung T, Chen XQ, Manser E, et al. The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton. Mol Cell Biol 1996;16:5313–27.
   PubMed Web of Science ®Google Scholar
• Kimura K, Ito M, Amano M, et al. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 1996;273:245–8.
   PubMed Web of Science ®Google Scholar
• Dong M, Yan BP, Liao JK, et al. Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseases. Drug Discov Today 2010;15:622–9.
   PubMed Web of Science ®Google Scholar
• Hartmann S, Ridley AJ, Lutz S. The function of rho-associated kinases ROCK1 and ROCK2 in the pathogenesis of cardiovascular disease. Front Pharmacol 2015;6:276
   PubMed Web of Science ®Google Scholar
• Defert O, Boland S. Rho kinase inhibitors: a patent review (2014 - 2016). Expert Opin Ther Pat 2017;27:507–15.
   PubMed Web of Science ®Google Scholar
• Asano T, Ikegaki I, Satoh S, et al. Mechanism of action of a novel antivasospasm drug, HA1077. J Pharmacol Exp Ther 1987;241:1033–40.
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Shibuya M, Satoh S-I, et al. A postmarketing surveillance study of fasudil treatment after aneurysmal subarachnoid hemorrhage. Surg Neurol 2007;68:126–31; discussion 131.
   PubMed Web of Science ®Google Scholar
• Chen M, Liu A, Ouyang Y, et al. Fasudil and its analogs: a new powerful weapon in the long war against central nervous system disorders? Expert Opin Investig Drugs 2013;22:537–50.
   PubMed Web of Science ®Google Scholar
• Guerra FS, Oliveira RG, de Fraga CAM, et al. ROCK inhibition with Fasudil induces beta-catenin nuclear translocation and inhibits cell migration of MDA-MB 231 human breast cancer cells. Sci Rep 2017;7:13723.
   PubMed Web of Science ®Google Scholar
• Duarte CD, Barreiro EJ, Fraga CAM. Privileged structures: a useful concept for the rational design of new lead drug candidates. Mini Rev Med Chem 2007;7:1108–19.
   PubMed Web of Science ®Google Scholar
• Avila CM, Lopes AB, Gonçalves AS, et al. Structure-based design and biological profile of (E)-N-(4-Nitrobenzylidene)-2-naphthohydrazide, a novel small molecule inhibitor of IκB kinase-β. Eur J Med Chem 2011;46:1245–53.
   PubMed Web of Science ®Google Scholar
• Guedes IA, Freitas RHCN, Cordeiro NM, et al. LASSBio-1829 hydrochloride: development of a new orally active N-acylhydrazone IKK2 inhibitor with anti-inflammatory properties. ChemMedChem 2016;11:234–44.
   PubMed Web of Science ®Google Scholar
• Freitas RHCN, Cordeiro NM, Carvalho PR, et al. Discovery of naphthyl- N -acylhydrazone p38α MAPK inhibitors with in vivo anti-inflammatory and anti-TNF-α activity. Chem Biol Drug Des 2018;91:391–97.
   PubMed Web of Science ®Google Scholar
• Schneider P, Hosseiny SS, Szczotka M, et al. Rapid solubility determination of the triterpenes oleanolic acid and ursolic acid by UV-spectroscopy in different solvents. Phytochem Lett 2009;2:85–7.
   Web of Science ®Google Scholar
• Pettersen EF, Goddard TD, Huang CC, et al. UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 2004;25:1605–12.
   PubMed Web of Science ®Google Scholar
• Laskowski RA, Swindells MB. LigPlot+: Multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model 2011;51:2778–86.
   PubMed Web of Science ®Google Scholar
• Doe C, Bentley R, Behm DJ, et al. Novel Rho kinase inhibitors with anti-inflammatory and vasodilatory activities. J Pharmacol Exp Ther 2007;320:89–98.
   PubMed Web of Science ®Google Scholar
• Turner MS, Fen-Fen-Lin Trauger JW, et al. Characterization and purification of truncated human Rho-kinase II expressed in Sf-21 cells. Arch Biochem Biophys 2002;405:13–20.
   PubMed Web of Science ®Google Scholar
• Beeren SR, Sanders JKM. Ferrocene-amino acid macrocycles as hydrazone-based receptors for anions. Chem Sci 2011;2:1560.
   Web of Science ®Google Scholar
• Nudelman A, Bechor Y, Falb E, et al. Acetyl chloride-methanol as a convenient reagent for:
   Google Scholar
  A) Quantitative formation of amine hydrochlorides B) carboxylate ester formation C) mild removal of N-t-Boc-protective group. Synth Commun 1998;28:471–4.
   Web of Science ®Google Scholar
• Lacerda RB, da Silva LL, de Lima CKF, et al. Discovery of novel orally active anti-inflammatory N-phenylpyrazolyl-N-glycinyl-hydrazone derivatives that inhibit TNF-α production. PLoS One 2012;7:e46925.
   PubMed Web of Science ®Google Scholar
• Ibiapino AL, de Figueiredo LP, Lima LM, et al. Structural and physicochemical characterization of sulfonylhydrazone derivatives designed as hypoglycemic agents. New J Chem 2017;41:6464–74.
   Web of Science ®Google Scholar
• Bastos ITS, Costa FN, Silva TF, et al. A combined experimental and in silico characterization to highlight additional structural features and properties of a potentially new drug. J Mol Struct 2017;1146:735–43.
   Web of Science ®Google Scholar
• de Figueiredo LP, Ibiapino AL, do Amaral DN, et al. Structural characterization and cytotoxicity studies of different forms of a combretastatin A4 analogue. J Mol Struct 2017;1147:226–34.
   Web of Science ®Google Scholar
• Silva TF, Bispo Júnior W, Alexandre-Moreira MS, et al. Novel orally active analgesic and anti-inflammatory cyclohexyl-N-acylhydrazone derivatives. Molecules 2015;20:3067–88.
   PubMed Web of Science ®Google Scholar
• Palla G, Predieri G, Domiano P, et al. Conformational behaviour and E/Z isomerization of N-acyl and N-aroylhydrazones. Tetrahedron 1986;42:3649–54.
   Web of Science ®Google Scholar
• Spek AL. Single-crystal structure validation with the program PLATON. J Appl Crystallogr 2003;36:7–13.
   Web of Science ®Google Scholar
• Macrae CF, Edgington PR, McCabe P, et al. Mercury: visualization and analysis of crystal structures. J Appl Crystallogr 2006;39:453–7.
   Web of Science ®Google Scholar
• Macrae CF, Bruno IJ, Chisholm JA, et al. Mercury CSD 2.0 – new features for the visualization and investigation of crystal structures. J Appl Crystallogr 2008;41:466–70.
   Web of Science ®Google Scholar
• Yamada S, Morizono D, Yamamoto K. Mild oxidation of aldehydes to the corresponding carboxylic acids and esters: alkaline iodine oxidation revisited. Tetrahedron Lett 1992;33:4329–32.
   Web of Science ®Google Scholar
• Kümmerle AE, Raimundo JM, Leal CM, et al. Studies towards the identification of putative bioactive conformation of potent vasodilator arylidene N-acylhydrazone derivatives. Eur J Med Chem 2009;44:4004–9.
   PubMed Web of Science ®Google Scholar
• Barreiro EJ, Kümmerle AE, Fraga CAM. The methylation effect in medicinal chemistry. Chem Rev 2011;111:5215–46.
   PubMed Web of Science ®Google Scholar
• Rikitake Y, Kim H-H, Huang Z, et al. Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection. Stroke 2005;36:2251–7.
   PubMed Web of Science ®Google Scholar
• Totsukawa G, Wu Y, Sasaki Y, et al. Distinct roles of MLCK and ROCK in the regulation of membrane protrusions and focal adhesion dynamics during cell migration of fibroblasts. J Cell Biol 2004;164:427–39.
   PubMed Web of Science ®Google Scholar